Literature DB >> 25775386

Examining trait mindfulness, emotion dysregulation, and quality of life in multiple sclerosis.

Brittney Schirda1, Jacqueline A Nicholas2, Ruchika Shaurya Prakash1.   

Abstract

OBJECTIVE: Dispositional mindfulness exhibits a positive association with quality of life (QoL). One potential mechanism for this association is enhanced emotion regulation abilities. Individuals with multiple sclerosis (MS) experience a range of physical, cognitive, and affective impairments, thus reducing overall QoL. The current cross-sectional study examines the relation between trait mindfulness and QoL, mediated by emotion dysregulation in individuals with MS.
METHOD: Ninety-five participants with self-reported MS completed an online survey that incorporated self-report measures of trait mindfulness, emotion dysregulation, and QoL. Although clinically significant depression was exclusionary, we observed a wide range of depressive symptoms in our sample. These scores were thus entered as a moderator in the mediation analysis.
RESULTS: Dispositional mindfulness correlated positively with QoL, with lower emotion dysregulation partially mediating the correlation. Depression scores moderated the observed mediation, such that the effect was stronger in those with higher symptoms of depression.
CONCLUSIONS: Trait mindfulness is positively associated with QoL in individuals with MS. Reduced emotion dysregulation may be a critical pathway linking mindfulness and QoL in MS, especially in those with higher symptoms of depression. (c) 2015 APA, all rights reserved).

Entities:  

Mesh:

Year:  2015        PMID: 25775386     DOI: 10.1037/hea0000215

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  9 in total

1.  Mindfulness in Motion for People with Multiple Sclerosis: A Feasibility Study.

Authors:  Rachel M Gilbertson; Maryanna D Klatt
Journal:  Int J MS Care       Date:  2017 Sep-Oct

Review 2.  The relationship between trait mindfulness and affective symptoms: A meta-analysis of the Five Facet Mindfulness Questionnaire (FFMQ).

Authors:  Joseph K Carpenter; Kristina Conroy; Angelina F Gomez; Laura C Curren; Stefan G Hofmann
Journal:  Clin Psychol Rev       Date:  2019-11-11

3.  A Comparison Between the Relaxation/Meditation/Mindfulness Tracker t Inventory and the Freiburg Mindfulness Inventory for Predicting General Health, Anxiety, and Anger in Adult General Population.

Authors:  Alireza Malakoutikhah; Mohammad Ali Zakeri; Mahlagha Dehghan
Journal:  Front Psychol       Date:  2022-04-04

4.  The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial.

Authors:  Sara Carletto; Martina Borghi; Diana Francone; Francesco Scavelli; Gabriella Bertino; Marco Cavallo; Simona Malucchi; Antonio Bertolotto; Francesco Oliva; Luca Ostacoli
Journal:  BMC Neurol       Date:  2016-01-13       Impact factor: 2.474

5.  The Effectiveness of a Body-Affective Mindfulness Intervention for Multiple Sclerosis Patients with Depressive Symptoms: A Randomized Controlled Clinical Trial.

Authors:  Sara Carletto; Valentina Tesio; Martina Borghi; Diana Francone; Francesco Scavelli; Gabriella Bertino; Simona Malucchi; Antonio Bertolotto; Francesco Oliva; Riccardo Torta; Luca Ostacoli
Journal:  Front Psychol       Date:  2017-11-30

6.  Distress and risk perception in people living with multiple sclerosis during the early phase of the COVID-19 pandemic.

Authors:  Kevin N Alschuler; Michelle K Roberts; Tracy E Herring; Dawn M Ehde
Journal:  Mult Scler Relat Disord       Date:  2020-11-05       Impact factor: 4.339

7.  Effect of Mindfulness Meditation on Personality and Psychological Well-being in Patients with Multiple Sclerosis.

Authors:  Cristiano Crescentini; Alessio Matiz; Matteo Cimenti; Eric Pascoli; Roberto Eleopra; Franco Fabbro
Journal:  Int J MS Care       Date:  2018 May-Jun

8.  Mindfulness-based stress reduction for people with multiple sclerosis - a feasibility randomised controlled trial.

Authors:  Robert Simpson; Frances S Mair; Stewart W Mercer
Journal:  BMC Neurol       Date:  2017-05-16       Impact factor: 2.474

Review 9.  Moral Judgment: An Overlooked Deficient Domain in Multiple Sclerosis?

Authors:  Samar S Ayache; Moussa A Chalah
Journal:  Behav Sci (Basel)       Date:  2018-11-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.